International Drug Safety Requirements Are Focus Of FDLI Conference Nov. 18
This article was originally published in The Pink Sheet Daily
Executive Summary
Drug safety execs from Amgen, Bayer, Watson and Pfizer will review legal and regulatory issues related to evolving pharmacovigilance requirements in the U.S. and Europe.